AZD0156 and the Next Frontier in Cancer Research: Mechani...

2025-10-21

This in-depth thought-leadership article explores the pivotal role of AZD0156—a potent, selective ATM kinase inhibitor—in revolutionizing cancer research. It blends mechanistic insights with strategic guidance, elucidating how ATM inhibition disrupts DNA double-strand break repair, drives metabolic adaptation, and exposes actionable vulnerabilities in tumor cells. Drawing on recent evidence, including the induction of macropinocytosis as a compensatory survival mechanism, we provide a roadmap for translational researchers to harness AZD0156 in next-generation therapeutic development. This article goes beyond conventional product summaries, offering visionary perspectives and practical strategies to accelerate translational impact.